Vaccination of Rats Against Yoshida Ascites Sarcoma
Author Information
Author(s): Helge J. C. Lund
Primary Institution: University Institute of Hygiene, Copenhagen, Denmark
Hypothesis
Can intracaecal injections of ascites sarcoma fluid induce resistance to the Yoshida ascites sarcoma in rats?
Conclusion
Intracaecal injection of sarcoma cells acts as a vaccination, leading to resistance against lethal injections of sarcoma cells due to the formation of a complement-fixing antibody.
Supporting Evidence
- Over 50 rats treated by intracaecal injections developed total resistance to further transplantations of the tumor.
- The resistance is due to the formation of a complement-fixing antibody in the serum of the rats.
- Rats that received intracaecal injections showed no antibody towards Yoshida sarcoma cells before treatment.
Takeaway
The study shows that giving rats a special injection can help them fight off a type of cancer, like a vaccine helps people fight off diseases.
Methodology
Rats received intracaecal injections of ascites sarcoma fluid, followed by intraperitoneal injections to test for resistance.
Participant Demographics
Rats of the State Vitamin Laboratory strain were used.
Want to read the original?
Access the complete publication on the publisher's website